Finance
Finance
Home01P • FRA
Medpace Holdings Inc
€368.40
Aug 6, 11:46:09 PM GMT+2 · EUR · FRA · Disclaimer
StockDE listed securityUS headquartered
Previous close
€375.70
Day range
€365.70 - €376.20
Year range
€227.70 - €405.90
Market cap
12.09B USD
Avg Volume
17.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD)Jun 2025Y/Y change
Revenue
603.31M14.24%
Operating expense
291.15M15.81%
Net income
90.26M2.16%
Net profit margin
14.96-10.58%
Earnings per share
3.1012.21%
EBITDA
133.35M18.65%
Effective tax rate
27.52%
Total assets
Total liabilities
(USD)Jun 2025Y/Y change
Cash and short-term investments
46.33M-90.93%
Total assets
1.57B-18.14%
Total liabilities
1.40B21.00%
Total equity
172.35M
Shares outstanding
28.09M
Price to book
61.09
Return on assets
18.21%
Return on capital
59.25%
Net change in cash
(USD)Jun 2025Y/Y change
Net income
90.26M2.16%
Cash from operations
148.53M27.60%
Cash from investing
-6.02M52.93%
Cash from financing
-540.56M-81,265.77%
Net change in cash
-395.11M-480.33%
Free cash flow
88.27M15.51%
About
Medpace Holdings, Inc. is a global clinical research organization based in Cincinnati, Ohio, employing approximately 6,000 people. Operating under a full-service model, the company also offers global central laboratory, imaging core laboratory, and bioanalytical laboratory services, as well as a Phase I unit located on its headquarters and clinical research campus in Cincinnati, Ohio. The company started trading stock as a public firm in 2016. Wikipedia
Founded
1992
Employees
6,000
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu